Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Arbormed logo — Diversified & balanced drug development & commercialization...

Arbormed

Diversified & balanced drug development & commercialization company with operations in S. Korea and USA

Founded 2017 Korea South Korea South 13 employees Biopharma, Pharmaceutical

General Information

Company Name Arbormed
Founded Year 2017
Location Korea South Korea South +2
Employees 13
Industries Biopharma, Pharmaceutical
Social

Get notified when Arbormed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Arbormed

Arbormed is a biopharmaceutical company founded in 2017 with a focus on developing and commercializing therapeutics for diseases with high unmet medical needs and untapped market opportunities. The company operates in South Korea and the US, utilizing resources efficiently to enable fast pipeline development and US market entry. Arbormed's Demand-Driven Development (D³) approach incorporates three strategic pillars to build a risk-balanced pipeline. These include innovative new drug development, focusing on rare diseases, and the commercialization of complex generics with limited competition in the US, developed by Korean companies. Arbormed's slogan, "Diversified & balanced drug development & commercialization company with operations in S. Korea and USA," reflects its commitment to a diversified and balanced approach in the biopharma and pharmaceutical industries. The company's focus on rare diseases and complex generics presents a unique opportunity for investors interested in the biopharmaceutical sector. Overall, Arbormed's strategic approach and operations in both South Korea and the US position the company as an attractive investment opportunity in the biopharmaceutical industry.

Taxonomy: biopharmaceuticals, drug development, commercialization, therapeutics, rare diseases, orphan drugs, pipeline development, innovation, fast-to-market strategy, demand-driven development, complex generics, US market entry, risk-balanced pipeline, preclinical stage, validated targets

No funding data available for Arbormed yet.

Get notified when Arbormed raises funding

Arbormed Alternatives & Competitors

Arbormed vs
K W LIMITED
K W LIMITED

Pioneering excellence in subsea pipeline consulting and engineering services with an impeccable indu...

18 employees
Arbormed vs
Aquestive Therapeutics
Aquestive Therapeutics United States

A pharmaceutical company advancing medicines to solve patients’ problems with current standards of c...

Post Ipo Equity
142 employees
Pharmaceutical
Arbormed vs
Baoling Bio
Baoling Bio

Leading the future of drug discovery with a focus on innovative treatments for tumors, autoimmune di...

Series B
Biopharma, Biotechnology

FAQ About Arbormed

Diversified & balanced drug development & commercialization company with operations in S. Korea and USA
Arbormed was founded in 2017.
Arbormed is headquartered in Korea South.
Arbormed operates in the following industries: Biopharma, Pharmaceutical.
Arbormed has approximately 13 employees.
Top alternatives and competitors to Arbormed include K W LIMITED, Aquestive Therapeutics, Baoling Bio, AGY Therapeutics, Neumora. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arbormed and K W LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arbormed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy